Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study

Affiliations

• ¹ Haematology Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
• ² Division of Haematology and Stem Cell Transplantation, University Hospital of Udine, Udine, Italy.
• ³ Haematology Unit, Spedali Civili di Brescia, Brescia, Italy.
• ⁴ Institute of Haematology, Fondazione Policlinico A. Gemelli - IRCCS-Università Cattolica S. Cuore, Roma, Italy.
• ⁵ Haematology Unit, Careggi Hospital and University of Firenze, Florence, Italy.
• ⁶ Division of Haematology and Stem Cell Transplantation, IRCCS San Raffaele, Milano, Italy.
• ⁷ Division of Haematology and Clinical Immunology, University of Padova, Padova, Italy.
• ⁸ Haematology and Stem Cell Transplantation Unit, Regina Elena National Cancer Institute, Roma, Italy.
• ⁹ Haematology and BMT Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
• ¹⁰ Division of Haematology, San Bortolo Hospital, Vincenza, Italy.
• ¹¹ Department of Clinical Medicine and Surgery, Federico II University Medical School, Napoli, Italy.
• ¹² Haematology and CTA ASST Monza, Milano Bicocca University, Ospedale San Gerardo, Monza, Italy.
• ¹³ Haematology and Stem Cell Transplantation Unit, 'Vito Fazzi' Hospital, Lecce, Italy.
• ¹⁴ SSD Division of Haematology and Stem Cell Transplantation, A.O.U. Città della Salute, Torino, Italy.